Compounds > gadolinium

Page last updated: 2024-08-22

gadolinium and mitoxantrone

gadolinium has been researched along with mitoxantrone in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	6 (66.67)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fetzer, U; Kornhuber, HH; Krapf, H; Laufen, H; Mauch, E	1
Beguin, C; Carton, H; D'Hooghe, MB; Dooms, G; Lissoir, F; Sindic, CJ; van de Wyngaert, FA	1
Castellà, MD; Montalban, X; Pericot, I; Río, J; Rovira, A; Tintoré, M	1
Burdette, J; Chepuri, N; Durden, D; Jeffery, DR	1
Nadeau, SE	1
Debouverie, M; Edan, G; Gout, O; Le Page, E; Malikova, I; Ory, S; Pelletier, J; Roullet, E; Vermersch, P	1
Arnold, DL; Bar-Or, A; Campagnolo, D; Dunn, J; Freedman, MS; Gazda, SK; Panitch, H; Vollmer, T	1
Comi, G; Edan, G; Filippi, M; Le Page, E; Leray, E; Rocca, MA	1
Aguglia, U; Amato, MP; Carreras, E; Currò, D; Di Bartolomeo, P; Di Gioia, M; Donelli, A; Farge, D; Filippi, M; Gualandi, F; Iacopino, P; Lugaresi, A; Mancardi, GL; Massacesi, L; Merelli, E; Rambaldi, A; Roccatagliata, L; Rottoli, MR; Saccardi, R; Saiz, A; Sormani, MP; Vuolo, L	1

Trials

6 trial(s) available for gadolinium and mitoxantrone

Article	Year
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis. Acta neurologica Belgica, 2001, Volume: 101, Issue:4 Topics: Adult; Alopecia; Contrast Media; Double-Blind Method; Female; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Lymphocyte Count; Magnetic Resonance Imaging; Male; Methylene Blue; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Nausea; Patient Dropouts; Phlebitis; Pulmonary Embolism; Pyrrolidines; Recurrence; Severity of Illness Index; Treatment Outcome; Vomiting	2001
A pilot trial of combination therapy with mitoxantrone and interferon beta-1b using monthly gadolinium-enhanced magnetic resonance imaging. Multiple sclerosis (Houndmills, Basingstoke, England), 2005, Volume: 11, Issue:3 Topics: Adjuvants, Immunologic; Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Gadolinium; Humans; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Male; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Pilot Projects; Severity of Illness Index	2005
[Use of mitoxantrone in early multiple sclerosis with malignant disease course. Observational study in 30 patients with clinical and MRI outcomes after one year]. Revue neurologique, 2008, Volume: 164, Issue:12 Topics: Adult; Disease Progression; Female; Gadolinium; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis; Retrospective Studies; Secondary Prevention; Treatment Outcome; Young Adult	2008
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS. Journal of neurology, 2008, Volume: 255, Issue:10 Topics: Adult; Brain; Drug Therapy, Combination; Female; Gadolinium; Glatiramer Acetate; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Organ Size; Peptides; Regression Analysis; Single-Blind Method	2008
Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial. Journal of neurology, neurosurgery, and psychiatry, 2011, Volume: 82, Issue:12 Topics: Adult; Brain; Drug Administration Schedule; Drug Therapy, Combination; Female; Gadolinium; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Neuroimaging; Severity of Illness Index	2011
Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial. Neurology, 2015, Mar-10, Volume: 84, Issue:10 Topics: Adult; Antineoplastic Agents; Female; Gadolinium; Hematopoietic Stem Cell Transplantation; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult	2015

Other Studies

3 other study(ies) available for gadolinium and mitoxantrone

Article	Year
Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone. Neuroradiology, 1995, Volume: 37, Issue:2 Topics: Adult; Brain; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mitoxantrone; Multiple Sclerosis	1995
Serial gadolinium-enhanced MRI in acute attack of multiple sclerosis treated with plasma exchange. Journal of neurology, 2003, Volume: 250, Issue:2 Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Plasma Exchange	2003
Effect of mitoxantrone on MRI in progressive MS: results of the MIMS trial. Neurology, 2006, May-09, Volume: 66, Issue:9 Topics: Adult; Brain; Contrast Media; Disease Progression; Gadolinium; Humans; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Randomized Controlled Trials as Topic; Research Design; Treatment Failure	2006